Applied DNA Reports FY’20 Q1 Results
February 6th, 2020
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
APDN Schedules FY’20 Q1 Financial Results Conference Call
January 30th, 2020
Innovation in Textiles | US Patent for CertainT in manmade cellulosic fibres
January 27th, 2020
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
January 27th, 2020
APDN Subsidiary, LineaRx, Inc., Sign Licensing Agreement with LifeSensors
January 13th, 2020
Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10th, 2020
Retailers Beware: Are Manufacturers Beating You at Brand Storytelling?
January 9th, 2020
Colorcon on-dose authentication platform for drug manufacturing
January 3rd, 2020
Applied DNA Sciences tags, tests and tracks with CertainT
January 2nd, 2020